In colitis-associated tumorigenesis and human CRC cohorts, heightened IL-11 signaling tracks with worse outcomes and promotes tumor cell survival by engaging STAT3—a pathway that drives target genes relevant to CRC biology, including SOCS3 and surviving. This evidence concerns the gene SOCS3 and colorectal carcinoma.